235 related articles for article (PubMed ID: 20585842)
41. Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal.
Zhang J; Lv H; Jiang K; Gao Y
Int J Pharm; 2011 Nov; 420(1):180-8. PubMed ID: 21878378
[TBL] [Abstract][Full Text] [Related]
42. Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation.
Jiang T; Han N; Zhao B; Xie Y; Wang S
Drug Dev Ind Pharm; 2012 Oct; 38(10):1230-9. PubMed ID: 22229827
[TBL] [Abstract][Full Text] [Related]
43. Development of isradipine loaded self-nano emulsifying powders for improved oral delivery: in vitro and in vivo evaluation.
Ramasahayam B; Eedara BB; Kandadi P; Jukanti R; Bandari S
Drug Dev Ind Pharm; 2015 May; 41(5):753-63. PubMed ID: 24641324
[TBL] [Abstract][Full Text] [Related]
44. Rutin nanosuspension for potential management of osteoporosis: effect of particle size reduction on oral bioavailability,
Gera S; Pooladanda V; Godugu C; Swamy Challa V; Wankar J; Dodoala S; Sampathi S
Pharm Dev Technol; 2020 Oct; 25(8):971-988. PubMed ID: 32403972
[TBL] [Abstract][Full Text] [Related]
45. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
[TBL] [Abstract][Full Text] [Related]
46. Enhanced oral bioavailability of glycyrrhetinic acid via nanocrystal formulation.
Lei Y; Kong Y; Sui H; Feng J; Zhu R; Wang W
Drug Deliv Transl Res; 2016 Oct; 6(5):519-25. PubMed ID: 27206446
[TBL] [Abstract][Full Text] [Related]
47. Enhanced dissolution and oral bioavailability of aripiprazole nanosuspensions prepared by nanoprecipitation/homogenization based on acid-base neutralization.
Xu Y; Liu X; Lian R; Zheng S; Yin Z; Lu Y; Wu W
Int J Pharm; 2012 Nov; 438(1-2):287-95. PubMed ID: 22989976
[TBL] [Abstract][Full Text] [Related]
48. Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour.
Lai F; Sinico C; Ennas G; Marongiu F; Marongiu G; Fadda AM
Int J Pharm; 2009 May; 373(1-2):124-32. PubMed ID: 19429297
[TBL] [Abstract][Full Text] [Related]
49. Etoposide Amorphous Nanopowder for Improved Oral Bioavailability: Formulation Development, Optimization, in vitro and in vivo Evaluation.
Wang Y; Wang S; Xu Y; Wang P; Li S; Liu L; Liu M; Jin X
Int J Nanomedicine; 2020; 15():7601-7613. PubMed ID: 33116490
[TBL] [Abstract][Full Text] [Related]
50. Fabrication of Ibrutinib Nanosuspension by Quality by Design Approach: Intended for Enhanced Oral Bioavailability and Diminished Fast Fed Variability.
Rangaraj N; Pailla SR; Chowta P; Sampathi S
AAPS PharmSciTech; 2019 Oct; 20(8):326. PubMed ID: 31659558
[TBL] [Abstract][Full Text] [Related]
51. The Evaluation of Meloxicam Nanocrystals by Oral Administration with Different Particle Sizes.
Yu Y; Tian Y; Zhang H; Jia Q; Chen X; Kang D; Du Y; Song S; Zheng A
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056734
[TBL] [Abstract][Full Text] [Related]
52. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
Jain S; Reddy VA; Arora S; Patel K
Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
[TBL] [Abstract][Full Text] [Related]
53. Solvent-mediated amorphous-to-crystalline transformation of nitrendipine in amorphous particle suspensions containing polymers.
Xia D; Wu JX; Cui F; Qu H; Rades T; Rantanen J; Yang M
Eur J Pharm Sci; 2012 Aug; 46(5):446-54. PubMed ID: 22484330
[TBL] [Abstract][Full Text] [Related]
54. Preparation and in vitro/in vivo Evaluation of Lacidipine by Adsorption onto Fumed Silica Using Supercritical Carbon Dioxide.
Geng Y; Fu Q; Guo B; Li Y; Zhang X; Wang X; Zhang T
Curr Drug Deliv; 2016; 13(7):1053-1064. PubMed ID: 26634790
[TBL] [Abstract][Full Text] [Related]
55. Effect of particle size on oral absorption of carvedilol nanosuspensions: in vitro and in vivo evaluation.
Liu D; Pan H; He F; Wang X; Li J; Yang X; Pan W
Int J Nanomedicine; 2015; 10():6425-34. PubMed ID: 26508852
[TBL] [Abstract][Full Text] [Related]
56. Preparation, characterization, and evaluation of dipfluzine-benzoic acid co-crystals with improved physicochemical properties.
Lin Y; Yang H; Yang C; Wang J
Pharm Res; 2014 Mar; 31(3):566-78. PubMed ID: 24065588
[TBL] [Abstract][Full Text] [Related]
57. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
[TBL] [Abstract][Full Text] [Related]
58. Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement.
Zhang J; Huang Y; Liu D; Gao Y; Qian S
Eur J Pharm Sci; 2013 Mar; 48(4-5):740-7. PubMed ID: 23305994
[TBL] [Abstract][Full Text] [Related]
59. Preparation and characterization of betulin nanoparticles for oral hypoglycemic drug by antisolvent precipitation.
Zhao X; Wang W; Zu Y; Zhang Y; Li Y; Sun W; Shan C; Ge Y
Drug Deliv; 2014 Sep; 21(6):467-79. PubMed ID: 24479653
[TBL] [Abstract][Full Text] [Related]
60. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
